Toxic exposure levels to aluminum can cause softening of the bones, reduced bone mineralization, neurological problems, microcytic hypochromic anemia, and a lessened or stopped bile flow, according to the regulatory agency.
Potassium phosphates injections are used in IV fluids “to correct hypophosphatemia and for parenteral nutrition in adults and pediatric patients,” the FDA said.
The alert recommended two FDA-approved drugs: Fresenius Kabi’s potassium phosphates drug for all ages, and CMP Development’s injection for patients 12 and older who weigh at least 88 pounds and adults who weigh at least 99 pounds.
